Literature DB >> 28430321

Comments to: Visual and anatomic outcomes after conversion to aflibercept in neovascular age-related macular degeneration: 12-month results.

Dan Călugăru1, Mihai Călugăru1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28430321     DOI： 10.5301/ejo.5000980

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN： 1120-6721            Impact factor:   2.597


× No keyword cloud information.
  1 in total

1.  Comment on "Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration".

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.